PharmaState Is Official Media Partner For DUPHAT 2022. Click the banner to explore more...spot_imgspot_imgspot_img

USFDA NEW DRUG APPROVAL

TALZENNA (Talazoparib) – A new drug to treat locally advanced or Metastatic Breast Cancer

TALZENNA full detail pdf link: Talzenna For any Feedback or suggestion mail at: info@pharmastate.com Weblink – https://pharmastate.com Applink- https://goo.gl/mS8Lr7

OXERVATE (Cenegermin) – For curing Neurotrophic Keratitis (a rare disease affecting the cornea)

OXERVATE (Cenegermin) Full Details PDF link: Oxervate The information in this presentation was compiled from sources believed to be reliable for informational purposes only. We do not guarantee the accuracy of this information or any results...

Recent posts

Popular categories